This paper, published in the journal Vaccine, investigates whether routine infant immunization with either currently licensed rotavirus vaccine could be cost-effective in Taiwan. The authors modeled specific disease outcomes …

This article, published in the journal Pediatrics, discusses a study to evaluate and compare the projected health and economic impact of meningococcal conjugate A/C/Y/W-135 (MCV-4) vaccination of adolescents, toddlers, and infants in the United …

This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine …

This fact sheet summarizes methods and results of cost-effectiveness analyses performed by PATH and its partners to determine the economic implications of introducing JE vaccine programs. The fact sheet is an excerpt from a larger, comprehensive …

This article, published in Vaccine, evaluates the cost-effectiveness of introducing infant rotavirus vaccination in Armenia in 2012 using Rotarix(R)® using a multiple birth cohort model. The model considered the cost and health implications of …

From the Bulletin of the World Health Organization, this article investigates the cost-effectiveness of JE immunization in China and demonstrates that a JE immunization program can be a cost-saving intervention for countries.

Epidemic meningococcal meningitis remains a serious health threat in the African meningitis belt. New meningococcal conjugate vaccines are relatively costly and their efficiency will depend on cost savings realized from no longer having to respond …

This article, published in Clinical Infectious Diseases, discusses an anthropologic and economic study in Burkina Faso to understand perceptions and behavior relative to meningitis and to determine the cost of illness from bacterial …

Investigators found that rotavirus gastroenteritis incurs considerable use of health care resources and results in substantial costs for families of patients and employers. Routine rotavirus vaccination could significantly reduce the related …

In studies conducted in the 1960s, children previously immunized with a formalin-inactivated respiratory syncytial virus (RSV) vaccine (FI-RSV) developed a greater incidence and severity of pulmonary disease during subsequent natural RSV infection …

This document provides details on PATH's partnership with the National Expanded Program on Immunization in Vietnam to enhance surveillance of JE disease and inform future immunization program planning.

Epidemic meningococcal meningitis continues to be an important worldwide cause of morbidity and mortality, especially in developing countries. Throughout its history, a number of "critical episodes" have occurred that have enhanced understanding of …

This article, published in The New England Journal of Medicine, describes a study to assess preexisting immunity in humans to the new pandemic influenza A(H1N1) virus in order to evaluate seasonal vaccine strategies. Researchers used a …

This issue brief discusses how ensuring swift and efficient HPV vaccine introduction in developing countries will not only help address the burden of cervical cancer, but will also provide a valuable opportunity for AIDS vaccine researchers and …

This article, published in Expert Reviews of Vaccines, explains the latest knowledge about the investigational 13-valent pneumococcal conjugate vaccine (PCV-13). It outlines the composition of the vaccine and the trials it has undergone to date …

This literature review, published in Expert Opinion on Biological Therapy, analyzes use of current JE vaccines and development of alternative vaccine candidates.

From the journal Tropical Medicine and International Health, this summary of surveillance data from Malaysia reveals seasonal peak incidence, age distribution of JE cases, and effect of the JE immunization program on disease incidence.

Published in the New England Journal of Medicine, this study examined population-based data from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prevention to evaluate changes in the burden of invasive disease, defined …

Published in The Lancet, this article assesses the effect of routine infant immunization with seven-valent pneumococcal conjugate vaccine (PCV7) on rates of all-cause and pneumococcal pneumonia admissions. ABSTRACT ONLY. (Learn how users in …

This website provides comprehensive resources on diarrheal disease treatment interventions, including low-osmolarity oral rehydration solution, zinc treatment, and rotavirus vaccines. Traditional interventions such as improved sanitation and …

This report highlights new partnerships and innovations in cervical cancer prevention and treatment. It also provides profiles of success in increasing access to HPV vaccines and treatment from around the world, with country spotlights on Mexico, …

This article, published in the World Health Organization's (WHO's) Weekly Epidemiological Record, provides the WHO recommendation for detecting and responding to meningococcal meningitis epidemics in highly-endemic countries in Africa. In each …

This fact sheet highlights PATH's work to develop safe, effective, and affordable vaccines against Shigella and enterotoxigenic Escherichia coli, two of the leading bacterial causes of diarrheal disease.

This fact sheet, issued by PATH, outlines PATH's pneumococcal vaccine project from a technical perspective, including an overview of PATH's vaccine development portfolio, research activities, and partners to support the development of vaccines …

This article, published in PLoS Medicine, provides an overview of the development and implementation of a national program for the management of severe and very severe childhood pneumonia in Malawi. Based on a successful delivery model used by the …